These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35797002)

  • 21. A model for designing intraocular pressure-regulating glaucoma implants.
    Pereira ICF; Wyss HM; Pinchuk L; Beckers HJM; den Toonder JMJ
    PLoS One; 2022; 17(9):e0273672. PubMed ID: 36054120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PreserFlo™ MicroShunt Versus Trabeculectomy in Patients With Moderate to Advanced Open-Angle Glaucoma: 12-Month Follow-Up of a Single-Center Prospective Study.
    Fili S; Kontopoulou K; Vastardis I; Perdikakis G; Kohlhaas M
    Cureus; 2022 Aug; 14(8):e28288. PubMed ID: 36158358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conventional glaucoma implants and the new MIGS devices: a comprehensive review of current options and future directions.
    Pereira ICF; van de Wijdeven R; Wyss HM; Beckers HJM; den Toonder JMJ
    Eye (Lond); 2021 Dec; 35(12):3202-3221. PubMed ID: 34127842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of endophthalmitis following needling procedure after PRESERFLO
    Brambati M; Bettin P; Ramoni A; Battista M; Bandello F
    Eur J Ophthalmol; 2022 May; 32(3):NP83-NP86. PubMed ID: 34015943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PreserFlo™ MicroShunt Versus Ab Externo Canaloplasty in Patients With Moderate to Advanced Open-Angle Glaucoma: 12-Month Follow-Up of a Single-Center Retrospective Study.
    Habbe KJ; Kohlhaas M; Fili S
    Cureus; 2023 Feb; 15(2):e35185. PubMed ID: 36960244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PreserFlo™ MicroShunt Combined with Phacoemulsification versus PreserFlo™ MicroShunt as a Standalone Procedure in Patients with Medically Resistant Open-Angle Glaucoma.
    Fili S; Kontopoulou K; Vastardis I; Perdikakis G; Bechrakis N; Kohlhaas M
    J Curr Ophthalmol; 2022; 34(2):180-186. PubMed ID: 36147269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraoperative primary partial occlusion of the PreserFlo MicroShunt to prevent initial postoperative hypotony.
    Lüke JN; Reinking N; Dietlein TS; Haendel A; Enders P; Lappas A
    Int Ophthalmol; 2023 Aug; 43(8):2643-2651. PubMed ID: 36905460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood Reflux Through a PreserFlo MicroShunt Device After Needling.
    Cassottana P; Di Mola I; Ferro Desideri L; Vagge A; Cutolo CA; Traverso CE; Iester M
    J Glaucoma; 2022 Dec; 31(12):979-981. PubMed ID: 35939834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-Year Follow-up of a Novel Aqueous Humor MicroShunt.
    Batlle JF; Fantes F; Riss I; Pinchuk L; Alburquerque R; Kato YP; Arrieta E; Peralta AC; Palmberg P; Parrish RK; Weber BA; Parel JM
    J Glaucoma; 2016 Feb; 25(2):e58-65. PubMed ID: 26766400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Case of Delayed-onset Hemorrhagic Choroidal Detachment After PreserFlo Microshunt Implantation in a Glaucoma Patient Under Anticoagulant Therapy.
    Micheletti E; Riva I; Bruttini C; Quaranta L
    J Glaucoma; 2020 Aug; 29(8):e87-e90. PubMed ID: 32568812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preserflo microshunt implant for the treatment of refractory uveitic glaucoma: 36-month outcomes.
    Triolo G; Wang J; Aguilar-Munoa S; Jayaram H; Barton K
    Eye (Lond); 2023 Aug; 37(12):2535-2541. PubMed ID: 36577805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on Minimally Invasive Glaucoma Surgery (MIGS) and New Implants.
    Brandão LM; Grieshaber MC
    J Ophthalmol; 2013; 2013():705915. PubMed ID: 24369494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of the PRESERFLO MicroShunt and a Meta-Analysis of the Literature.
    Pawiroredjo SSM; Bramer WM; Pawiroredjo ND; Pals J; Poelman HJ; de Vries VA; Wolfs RCW; Ramdas WD
    J Clin Med; 2022 Dec; 11(23):. PubMed ID: 36498729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypotony in the early postoperative period after MicroShunt implantation versus trabeculectomy: A registry study.
    Bøhler AD; Traustadóttir VD; Hagem AM; Tønset TS; Drolsum L; Kristianslund O
    Acta Ophthalmol; 2024 Mar; 102(2):186-191. PubMed ID: 37340695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimally Invasive Glaucoma Surgery: A Critical Appraisal of the Literature.
    Mathew DJ; Buys YM
    Annu Rev Vis Sci; 2020 Sep; 6():47-89. PubMed ID: 32936738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimizing the invasiveness of traditional trabeculectomy surgery.
    Condon GP; Moster MR
    J Cataract Refract Surg; 2014 Aug; 40(8):1307-12. PubMed ID: 25088628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of PreserFlo
    Quaranta L; Micheletti E; Carassa R; Bruttini C; Fausto R; Katsanos A; Riva I
    Adv Ther; 2021 Aug; 38(8):4403-4412. PubMed ID: 34251652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A New and Easier Approach to Preserflo MicroShunt Implantation.
    Fea AM; Ghilardi A; Bovone D; Reibaldi M; Rossi A; Craven ER
    Clin Ophthalmol; 2022; 16():1281-1288. PubMed ID: 35510275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One-year outcomes of stand-alone ab externo SIBS microshunt implantation in refractory glaucoma.
    Durr GM; Schlenker MB; Samet S; Ahmed IIK
    Br J Ophthalmol; 2022 Jan; 106(1):71-79. PubMed ID: 33097520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Learning from the past: Mitomycin C use in trabeculectomy and its application in bleb-forming minimally invasive glaucoma surgery.
    Bell K; de Padua Soares Bezerra B; Mofokeng M; Montesano G; Nongpiur ME; Marti MV; Lawlor M
    Surv Ophthalmol; 2021; 66(1):109-123. PubMed ID: 32450159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.